ArticleNPJ biofilms and microbiomes2026
Gut commensal Parabacteroides goldsteinii protects against Salmonella infection in mice by enhancing innate defense function.
Article in NPJ biofilms and microbiomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Bacterial enteritis caused by the invasion of Salmonella enterica subsp. enterica serovar Typhimurium into the intestinal epithelium is often associated with the overactivation of the immune system, production of proinflammatory cytokines, disruption of the intestinal barrier and dysbiosis of gut microbiota. In this study, the gut commensal Parabacteroides goldsteinii isolated from the feces of mice and enriched after consumption of Hirsutella sinensis mycelium (HSM) was selected to evaluate its ameliorative effect on enteritis. S. typhimurium was used to establish an enteritis model in mice and the effects of orally administered heat-killed P. goldsteinii were evaluated. The results indicated that P. goldsteinii reduced the systemic burdens of S. typhimurium, restored mucosal barrier integrity, decreased overexpression of genes involved in inflammation, and modulated the composition of gut microbiota, leading to the amelioration of enteritis. A subsequent transcriptomic study in germ-free mice highlighted that P. goldsteinii administration increased the expression of α-defensins, Reg3g, lyz1, and CARD9, which are involved in mucosal defense mechanisms. The increased expression of these factors was validated in infected specific-pathogen free (SPF) mice. The results indicated that P. goldsteinii may enhance intestinal immunity, leading to a reduction in S. typhimurium pathogenicity. P. goldsteinii may be developed as a food supplement for the amelioration of S. typhimurium infection-associated enteritis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.